S THE MICROBICIDE DEVELOPMENT STRATEGY Worldwide / Lomangino Studio Inc. / HIV Resource Tracking Working Group / Phase / AMD / McKinsey & Company / /
Country
United States / United Kingdom / /
Currency
USD / /
Event
FDA Phase / /
IndustryTerm
active site / crucial prevention products / private systems / pharmaceutical industry / HIV prevention / model systems / health products / microbicide products / physical infrastructure / manufacturing / pharmaceutical / /
MedicalCondition
HIV infection / HIV / HPV / sexual infection / herpes / human papilloma virus HSV / HIV infections / Malaria HPTN / sexually transmitted infections / AIDS / infection / Tuberculosis / /
Organization
Department for International Development / Melinda Gates Foundation / Rockefeller Foundation / National Institute of Health / United States Agency for International Development / World Health Organization / Food and Drug Administration / MHRA / United Nations / United Kingdom MSM / Alliance for Microbicide Development Dosage / R5 and X4 Chapter / European Union / Alliance for Microbicide Development / European Union FDA / Medicines and Healthcare Products Regulatory Agency / Medical Research Council / United Kingdom MRC / UNAIDS / Global Fund / Centers for Disease Control and Prevention / /
Person
Jeff Hoover / Janet Darbyshire / Sam Avrett / Renee Ridzon / Andrew Nunn / Silver Spring / Joe Romano / Patricia Kahn / Bill Rencher / Emily Bass / Sharon Hillier / Carolyn Plescia / Ari Silverman / Salim Abdool Karim / Polly Harrison / Tim Farley / Matt Montelongo / Alan Stone / Liz McGrory / /
M.D . S THE MICROBICIDE DEVELOPMENT STRATEGY